- Home
- PPBI vs NEO Comparison
PPBI vs NEO Comparison
Compare PPBI & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBI
- NEO
- Stock Information
- Founded
- PPBI 1983
- NEO 2001
- Country
- PPBI United States
- NEO United States
- Employees
- PPBI N/A
- NEO N/A
- Industry
- PPBI Major Banks
- NEO Precision Instruments
- Sector
- PPBI Finance
- NEO Health Care
- Exchange
- PPBI Nasdaq
- NEO Nasdaq
- Market Cap
- PPBI 2.5B
- NEO 2.1B
- IPO Year
- PPBI 1997
- NEO 1999
- Fundamental
- Price
- PPBI $27.75
- NEO $15.04
- Analyst Decision
- PPBI Buy
- NEO Strong Buy
- Analyst Count
- PPBI 6
- NEO 9
- Target Price
- PPBI $26.50
- NEO $19.89
- AVG Volume (30 Days)
- PPBI 587.4K
- NEO 792.3K
- Earning Date
- PPBI 10-24-2024
- NEO 11-05-2024
- Dividend Yield
- PPBI 4.76%
- NEO N/A
- EPS Growth
- PPBI N/A
- NEO N/A
- EPS
- PPBI N/A
- NEO N/A
- Revenue
- PPBI $379,785,000.00
- NEO $644,118,000.00
- Revenue This Year
- PPBI N/A
- NEO $12.93
- Revenue Next Year
- PPBI N/A
- NEO $9.70
- P/E Ratio
- PPBI N/A
- NEO N/A
- Revenue Growth
- PPBI N/A
- NEO 12.06
- 52 Week Low
- PPBI $20.52
- NEO $12.77
- 52 Week High
- PPBI $30.13
- NEO $21.22
- Technical
- Relative Strength Index (RSI)
- PPBI 57.46
- NEO 52.58
- Support Level
- PPBI $24.43
- NEO $13.35
- Resistance Level
- PPBI $29.01
- NEO $16.60
- Average True Range (ATR)
- PPBI 0.90
- NEO 0.67
- MACD
- PPBI 0.12
- NEO 0.18
- Stochastic Oscillator
- PPBI 63.72
- NEO 53.98
About PPBI Pacific Premier Bancorp Inc
Pacific Premier Bancorp Inc through its subsidiaries, provides banking products and services. It offers cash management, electronic banking services, credit facilities, and retirement accounts, among others.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.